Thought Leadership
COVID Booster Vaccines: What’s Next for FDA
September 13, 2021
Kristin Brooks
Contract Pharma

Axinn partner David Silverstein was quoted in the Contract Pharma article, "COVID Booster Vaccines: What’s Next for FDA."

Click here to access the article

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.